Notice: unserialize(): Error at offset 2 of 31 bytes in /data/html/www_bioworld_com/includes/bootstrap.inc on line 559 Notice: unserialize(): Error at offset 2753 of 5598 bytes in /data/html/www_bioworld_com/includes/bootstrap.inc on line 559 Early Phase III Data Hint at Rituxan Replacement | BioWorld

Login to Your Account



Early Phase III Data Hint at Rituxan Replacement

By Marie Powers
Staff Writer

Thursday, January 31, 2013
Genentech Inc., a unit of the Roche Group, could add another agent to its formidable oncology arsenal if initial findings from a Phase III study of lead hematology candidate GA101 (obinutuzumab) are borne out in a three-arm trial.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription